Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

Space Compass and SWISSto12 have executed a procurement contract for the first GEO optical data relay satellite. This agreement represents a milestone toward the realisation of Space Compass’s optical ...

Magnetic rocks with iron oxide concentrations act as natural chroniclers of Earth's past continental movements. Using small ...

(From Left to Right): Julie Pignon, Legal Counsel, SWISSto12; 倉田 るり子 (Ruriko Kurata), Legal Counsel, Space Compass; 小松 大実 (Hiromi Komatsu), Co-CEO, Space Compass; 田中 良太 (Ryota Tanaka), Engineering ...

Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...

A Compass sales manager argues MLS exposure is valuable but not always optimal, and says pre market sequencing can reduce price adjustment risk. He cites Compass data that 93% of listings involve ...

Before downloading the whitepaper, we would like to ask you to complete your profile with company and position. After confirming you will receive the white paper.

Access detailed historical stock prices, including daily closing prices, for COMP. Analyze past performance trends, track price movements, and explore historical data to inform your investment ...